A new study led by scientists at Oxford University have found the link between strep throat and rheumatic heart disease could be dependent on a patient’s genetic makeup, not just how quickly they receive antibiotics, reports the New York Times.
The new findings could help find a vaccine for Group A streptococcus bacteria, which is responsible for strep, scarlet fever and rheumatic heart disease.
In poorer countries, more than 230,000 people die of rheumatic heart disease every year. The study, published in Nature Communications, was conducted in Fiji, New Caledonia and other South Pacific islands because the disease is rampant there.
To read the full article, follow the link below:
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.